about
Susceptibility pathways in Fanconi's anemia and breast cancerCigarette smoke induces genetic instability in airway epithelial cells by suppressing FANCD2 expressionSex hormones, acting on the TERT gene, increase telomerase activity in human primary hematopoietic cellsThe inherited bone marrow failure syndromesRoles of brca2 (fancd1) in oocyte nuclear architecture, gametogenesis, gonad tumors, and genome stability in zebrafishInsights into Fanconi Anaemia from the structure of human FANCECellular and molecular consequences of defective Fanconi anemia proteins in replication-coupled DNA repair: mechanistic insightsThe Fanconi anemia pathway and ubiquitinCurrent diagnosis of inherited bone marrow failure syndromes.Frequency and natural history of inherited bone marrow failure syndromes: the Israeli Inherited Bone Marrow Failure Registry.Diagnosis of myelodysplastic syndrome among a cohort of 119 patients with fanconi anemia: morphologic and cytogenetic characteristics.Significance of the Fanconi anemia FANCD2 protein in sporadic and metastatic human breast cancerPreclinical correction of human Fanconi anemia complementation group A bone marrow cells using a safety-modified lentiviral vector.Human FANCC is hypomorphic in murine Fancc-deficient cellsGenetic disruption of both Fancc and Fancg in mice recapitulates the hematopoietic manifestations of Fanconi anemia.Bone marrow cell transcripts from Fanconi anaemia patients reveal in vivo alterations in mitochondrial, redox and DNA repair pathways.Stem cell gene therapy for fanconi anemia: report from the 1st international Fanconi anemia gene therapy working group meeting.TNF-alpha induces leukemic clonal evolution ex vivo in Fanconi anemia group C murine stem cells.The fanconi anemia pathway limits human papillomavirus replicationTelomere maintenance and human bone marrow failureMechanisms leading to nonrandom, nonhomologous chromosomal translocations in leukemiaGenetic heterogeneity among Fanconi anemia heterozygotes and risk of cancerAllogeneic hematopoietic cell transplantation for fanconi anemia in patients with pretransplantation cytogenetic abnormalities, myelodysplastic syndrome, or acute leukemiaOvernight transduction with foamyviral vectors restores the long-term repopulating activity of Fancc-/- stem cells.Interleukin 8/KC enhances G-CSF induced hematopoietic stem/progenitor cell mobilization in Fancg deficient mice.Pathophysiology and management of inherited bone marrow failure syndromes.Myelodysplasia and acute leukemia as late complications of marrow failure: future prospects for leukemia prevention.Silencing of fanconi anemia complementation group f exhibits potent chemosensitization of mitomycin C activity in breast cancer cells.Fanca-/- hematopoietic stem cells demonstrate a mobilization defect which can be overcome by administration of the Rac inhibitor NSC23766.Mesenchymal stem/progenitor cells promote the reconstitution of exogenous hematopoietic stem cells in Fancg-/- mice in vivo.Fanconi anemia: a signal transduction and DNA repair pathway.Coordinate regulation of Fanconi anemia gene expression occurs through the Rb/E2F pathway.The DNA translocase FANCM/MHF promotes replication traverse of DNA interstrand crosslinks.TLR8-dependent TNF-(alpha) overexpression in Fanconi anemia group C cells.DNA interstrand crosslink repair in mammalian cells.Advances in the prognostication and management of advanced MDS in children.Current clinical management of Fanconi anemia.DNA damage response, redox status and hematopoiesis.Stress and DNA repair biology of the Fanconi anemia pathwayBiomarkers and mechanisms of FANCD2 function
P2860
Q24628760-DA482480-D24B-42E3-A7B6-DBECBAA0060BQ24652399-FB8D33F6-4912-47ED-8ECF-349EA79B6D65Q24652633-E872D14B-503E-46BB-BF06-89793E84B379Q26999046-9D20F233-5DEE-4B79-A134-29F9BC4850ECQ27342643-CB1D026C-A10E-4CFB-A5F1-66DD98337745Q27643858-142D7893-9528-4DC4-BB38-5CAB3F7FA486Q28252640-FC662A60-F46B-4C53-A41A-805E859502F0Q28756516-846A59D1-ACED-4F39-B5F1-5AFF452253E0Q33374981-BA38B2D4-5999-49A8-985B-97075A71739FQ33389382-D911E4B2-6AC0-456B-B193-0E97D632470AQ33787288-C548AB2F-356A-494B-A7C2-BDFF26C2BF14Q33882536-66771F6D-00CA-4AC7-A26A-3E6D2358056EQ34082330-85192625-9D1A-49DD-95B6-8249D5B6C7C1Q34184712-1ECC351D-ED12-4876-8385-1AD191F85552Q34282323-0E95583E-66FD-4C1B-96AF-B06E99E0E6DAQ34707383-6607FF41-6344-4D62-AA5A-C9BF406C6F75Q35086128-7D7E6645-9B89-4260-983D-BEAE91176AC0Q36088939-FCE83372-FE35-4675-A6AF-4BA873EAF791Q36171920-FE1DB363-B72D-4E74-BB3E-5FCCE685F9ECQ36591289-CB71803B-0CAB-4C44-9D6D-07A9CF36D439Q36677854-7568D43E-818F-427D-991A-3066FDB6098EQ36754598-5D82D53C-438A-4CF8-9228-7AB375574117Q36792446-98FE8E7E-99C3-4057-9EDD-9B4107914178Q37001945-E22955DD-4298-4213-A549-38BF81A449C3Q37044047-1F3336E3-1447-41E9-8736-2E789428FA09Q37070448-0188A322-A4A8-4591-9406-C958A5C0EC6BQ37229440-AB517A34-3C6A-451D-86EA-8B184344448AQ37240042-474FC225-E22E-4BAA-AE1B-B3966D7EED68Q37246770-6E4E0770-1936-4F01-A15D-7476DA1B28EEQ37342808-6D4D9444-50FB-4E47-BC81-5B6D5C141AF5Q37358559-5F4006F0-EEE2-482D-BC6F-18285444426CQ37374618-35C64249-C152-46C5-A4ED-6C5EAA8956ECQ37430268-F1BA8A79-B460-4ABC-BB1B-70044383B830Q37484487-1EEEFA78-36ED-4476-9985-9CEB0C15D6F2Q37487925-E2C100BC-B435-424A-AB05-1D0CF92AACDAQ37873542-0B5449BA-E08E-4BE2-8139-EC58264619A3Q38059251-6ED49126-F6E3-4344-B6D9-B9B2C5BFE3D7Q38138224-E9B70AFC-975E-415D-AF05-2583A3B1FD2EQ38252562-7EB16496-BBC3-490F-8288-A2FDA3F0DFECQ38287129-4F0878CC-7F25-40EC-B8E0-B49C309D4166
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Fanconi anemia.
@ast
Fanconi anemia.
@en
Fanconi anemia.
@nl
type
label
Fanconi anemia.
@ast
Fanconi anemia.
@en
Fanconi anemia.
@nl
prefLabel
Fanconi anemia.
@ast
Fanconi anemia.
@en
Fanconi anemia.
@nl
P1476
Fanconi anemia
@en
P2093
Blanche P Alter
P304
P356
10.1053/J.SEMINHEMATOL.2006.04.005
P577
2006-07-01T00:00:00Z